Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Overview of Hematopoiesis

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

Erythropoiesis

Erythropoiesis

Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Recent advances in individualized treatment for pediatric high-risk B-cell acute lymphoblastic leukemia].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2026

Same author

Experience of using a virtual reality rehabilitation management platform for breast cancer patients: a qualitative study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023

Same author

Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction.

Scientific reports·2023

Same author

Deep learning-powered 3D segmentation derives factors associated with lymphovascular invasion and prognosis in clinical T1 stage non-small cell lung cancer.

Heliyon·2023

Same author

AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function.

Journal of Cancer·2023

Same author

Long-Term Outcomes after Pediatric Mandibular Reconstruction Using Vascularized Free Fibula Flap.

Plastic and reconstructive surgery·2023

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

[Research Progress on the Bone Marrow Microenvironment in Beta-Thalassemia --Review].

Xin Peng¹, Ya-Jie Wang², Zeng-Zheng Li²

¹Department of Pediatrics, The 2nd Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi

|June 2, 2026

Summary

Beta-thalassemia, a common genetic blood disorder, damages the bone marrow microenvironment through iron overload and ineffective red blood cell production. Correcting this microenvironment is crucial for effective thalassemia treatment.

Keywords:

beta-thalassemia; bone marrow microenvironment; stem cell transplantation; extracellular vesicle; traditional Chinese medicine treatment

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

Area of Science:

Hematology
Genetics
Cell Biology

Background:

Thalassemia is a prevalent single-gene recessive disorder affecting hemoglobin production.
Beta-thalassemia involves defects in beta-globin synthesis, leading to alpha-beta globin chain imbalance.
This imbalance causes iron overload and ineffective erythropoiesis, damaging the bone marrow microenvironment.

Purpose of the Study:

To review the mechanisms of bone marrow microenvironment destruction in beta-thalassemia.
To explore therapeutic strategies for improving the bone marrow microenvironment.
To discuss the role of stem cell transplantation in managing beta-thalassemia.

Main Methods:

Literature review of studies on beta-thalassemia and bone marrow microenvironment.
Analysis of research on iron overload and ineffective erythropoiesis.
Synthesis of data on mesenchymal stem cells, osteoblasts, and osteoclasts in thalassemia.

Main Results:

Beta-thalassemia significantly alters the bone marrow microenvironment.
Iron overload and ineffective erythropoiesis are key contributors to microenvironment destruction.
Changes in bone marrow cells exacerbate hematopoietic system damage.

Conclusions:

Restoration of the bone marrow microenvironment is essential for treating beta-thalassemia.
Targeting microenvironmental defects offers promising therapeutic avenues.
Stem cell transplantation shows potential for comprehensive treatment.